Pentraxin 3 in Cardiovascular Disease
Pentraxin 3 in Cardiovascular Disease
Giuseppe Ristagno1*, Francesca Fumagalli1, Barbara Bottazzi2, Alberto Mantovani2,3,4, Davide Olivari1, Deborah Novelli1 and Roberto Latini1
1Department of Cardiovascular Research, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy
2Humanitas Clinical and Research Center-IRCCS, Milan, Italy
3Humanitas University, Milan, Italy
4The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom
The long pentraxin PTX3 is a member of the pentraxin family produced locally by stromal and myeloid cells in response to proinflammatory signals and microbial moieties. The prototype of the pentraxin family is C reactive protein (CRP), a widely-used biomarker in human pathologies with an inflammatory or infectious origin. Data so far describe PTX3 as a multifunctional protein acting as a functional ancestor of antibodies and playing a regulatory role in inflammation. Cardiovascular disease (CVD) is a leading cause of mortality worldwide, and inflammation is crucial in promoting it. Data from animal models indicate that PTX3 can have cardioprotective and atheroprotective roles regulating inflammation. PTX3 has been investigated in several clinical settings as possible biomarker of CVD. Data collected so far indicate that PTX3 plasma levels rise rapidly in acute myocardial infarction, heart failure and cardiac arrest, reflecting the extent of tissue damage and predicting the risk of mortality.
...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Angioplasty | Arthritis | Aspergillosis | Atrial Fibrillation | Autoimmune Disease | Biology | Brain | Brain Cancers | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Cholesterol | Chronic Kidney Disease | Coronary Angioplasty | Crestor | Dengue Fever | Diabetes | Diabetes Type 2 | Dialysis | Dysentery | Eating Disorders & Weight Management | Endocrinology | Epidemiology | Finland Health | Funding | Fungal Infections | Gastroenteritis | Gastroschisis Repair | Genetics | Heart | Heart Attack | Heart Failure | Heart Transplant | Hemodialysis | Hepatocellular Carcinoma | Hospitals | Inflammatory Bowel Disease | Intensive Care | International Medicine & Public Health | Ischemic Stroke | Italy Health | Kidney Transplant | Kidney Transplantation | Liver | Liver Cancer | Liver Transplant | Lung Transplant | Lupus | Men | Meningitis | Molecular Biology | Myeloproliferative Disorders | Myocarditis | Nasopharyngeal Cancer | Neurology | Obesity | Orthopaedics | Pathology | Percutaneous Coronary Intervention | Perfusion | Peripheral Vascular Disease (PVD) | PET Scan | Pregnancy | Proteinuria | Reproduction Medicine | Rheumatoid Arthritis | Rheumatology | Rosuvastatin | Septic Shock | Skin | Statin Therapy | Stem Cell Therapy | Stem Cells | Stroke | Study | Thrombosis | Transplant Surgery | Transplants | Tuberculosis | UK Health | Ulcerative Colitis | Urology & Nephrology | Vasculitis | WHO | Women